Hydroxychloroquine in Prevention of Preeclampsia

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 1, 2021

Primary Completion Date

July 30, 2023

Study Completion Date

July 30, 2023

Conditions

Preeclampsia

Interventions

DRUG

Hydroxychloroquine

Hydroxychloroquine 400 mg at start of pregnancy

DRUG

Folic acid

5 mg

DRUG

Low-dose aspirin

75 mg

Trial Locations (1)

Abdel-rahman Mahmoud Mohammed, Asyut

All Listed Sponsors

lead

Assiut University

OTHER

NCT04755322 - Hydroxychloroquine in Prevention of Preeclampsia | Biotech Hunter | Biotech Hunter